Keyword: Bristol-Myers Squibb (BMS)
News
26.06.2017
- Last week’s 8-1 ruling by the US Supreme Court in a long-running case brought against Bristol-Myers Squibb (BMS) and California-based drug distributor McKesson Corp – which could...
News
03.05.2017
- Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...
News
27.04.2017
- Bristol-Myers Squibb has announced another collaboration to use Opdivo in a combination cancer treatment, this time working with French biotech Transgene. The potential new therapy...
News
21.04.2017
- US pharmaceutical companies Bristol-Myers Squibb and Apexigen are collaborating to test a combination of their respective drugs to treat patients with advanced solid tumors...
News
16.02.2017
- UK household goods giant Reckitt Benckiser has agreed to buy US baby milk maker Mead Johnson for $16.6 billion. Its cash offer of $90 per share has been accepted by Mead Johnson’s...
News
03.02.2017
- UK consumer goods company Reckitt Benckiser is in advanced negotiations to buy US-based Mead Johnson Nutrition in a deal valued at $16.7 billion. The acquisition would take the...
News
24.01.2017
- US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...
News
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
